Cognition Therapeutics, Inc.
CGTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $19,731 | $26,017 | $32,562 |
| - Cash | $39,823 | $10,743 | $16,428 | $25,009 |
| + Debt | $212 | $427 | $635 | $814 |
| Enterprise Value | – | $9,415 | $10,224 | $8,367 |
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$61 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4,869 | -$6,670 | -$8,430 | -$7,766 |
| % Margin | – | – | – | – |
| Net Income | -$4,930 | -$6,734 | -$8,480 | -$7,842 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.06 | -0.11 | -0.14 | -0.17 |
| % Growth | 45.5% | 21.4% | 17.6% | – |
| Operating Cash Flow | -$5,651 | -$5,623 | -$9,877 | -$8,382 |
| Capital Expenditures | $0 | $0 | $0 | -$1 |
| Free Cash Flow | -$5,651 | -$5,623 | -$9,877 | -$8,383 |